Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Ovarian cancer
Closed
Phase 2
This trial is looking at using PankoMab-GEX after chemotherapy for ovarian cancer that has come back. It is for women who have:
These cancers are treated in a similar way. When we use the term ovarian cancer in this summary, we are referring to all 3.
Recruitment start: 13 November 2013
Recruitment end: 31 August 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Jonathan Ledermann
Glycotope
Last reviewed: 27 Sept 2016
CRUK internal database number: 13406